SCHEMBL24725399

SCHEMBL24725399

Cc1ccc2c(c1)c1ccccc1n2-c1c(C#N)c(-n2c3ccccc3c3cc(C)ccc32)c(-n2c3ccccc3c3ccc4c5ccccc5oc4c32)c(C#N)c1-n1c2ccccc2c2cc(C)ccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.34
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PGR P06401 1/20 0.32
PDE9A O76083 1/20 0.31
PDE1C Q14123 1/20 0.31
MAPK1 P28482 1/20 0.31
STAT3 P40763 1/20 0.31
LMNA P02545 2/20 0.31
PPARG P37231 2/20 0.31
RXFP1 Q9HBX9 2/20 0.31
NR2E3 Q9Y5X4 2/20 0.31
NCOR2 Q9Y618 2/20 0.31
ADORA2A P29274 1/20 0.31
TP53 P04637 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24725392 1.00 MAOB (0.34) MAOBALDH1A1KDM4EMAPTHPGD
SCHEMBL24725522 1.00 MAOB (0.34) MAOBALDH1A1KDM4EMAPTHPGD
SCHEMBL23351889 1.00 MAOB (0.34) MAOBALDH1A1KDM4EMAPTHPGD
SCHEMBL24725518 1.00 MAOB (0.34) MAOBALDH1A1KDM4EMAPTHPGD
SCHEMBL23351566 1.00 MAOB (0.34) MAOBALDH1A1KDM4EMAPTHPGD
SCHEMBL23351659 0.98 MAOB (0.33) MAOBALDH1A1KDM4EMAPTHPGD
SCHEMBL23351836 0.98 MAOB (0.33) MAOBALDH1A1KDM4EMAPTHPGD
SCHEMBL21656086 0.98 MAOB (0.33) MAOBALDH1A1KDM4EMAPTHPGD
SCHEMBL23351898 0.98 MAOB (0.33) MAOBALDH1A1KDM4EMAPTHPGD
SCHEMBL24725689 0.98 MAOB (0.35) MAOBALDH1A1KDM4EMAPTPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220263030-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220263030-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE RAE1, RER1, ESR1 MAOB 1734/4885ALDH1A1 94/4885KDM4E 1877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.